Dr. Daniel Fonzari Mindlin, MD

Dr. Mindlin practices at Providence Alaska Medical Center in Anchorage, Alaska, part of Providence Health & Services.

Dr. Mindlin's NPI, 1295097301, was assigned on June 14, 2012. Dr. Mindlin graduated from Icahn School Of Medicine At Mount Sinai in 2012. Dr. Mindlin holds California license A128386.

Dr. Mindlin's primary practice is Providence Alaska Medical Center, at 3200 Providence Drive, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 562-2211.

Dr. Mindlin's primary practice is Providence Alaska Medical Center in Anchorage, Alaska, part of Providence Health & Services. The medical group on file is Alaska Native Medical Center. Dmand AI also links Dr. Mindlin to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mindlin practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. Mindlin's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Mindlin is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Mindlin's licenses on file in 2 states: California and Alaska.

CMS data shows 357 Medicare services from Dr. Mindlin across 3 procedure codes in 2024, for 356 Medicare patients. Medicare paid $64,778 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 356 Medicare patients who saw Dr. Mindlin in 2024. The largest group is 65 to 74, with 137 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mindlin's median patient age at 63, with 57% women.

In 2024, Dr. Mindlin wrote 89 Medicare Part D claims for 70 patients. 89% of them were for generic drugs. CMS names the drug for 30 of them, across 2 drugs with 11 or more claims each, at $173 in total drug cost. In 2022, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Mindlin for performance year 2024, reported as part of a group. Dr. Mindlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dr. Mindlin graduated from Icahn School Of Medicine At Mount Sinai in 2012.

Dr. Mindlin is in network with 3 carriers, including AK State Medicaid, CMS Medicare and GA State Medicaid. Medicaid plans come from the most carriers, 2. Check the plan with the practice before a visit.